(American Associates, Ben-Gurion University of the Negev) Having a reliable personalized prediction platform could improve patient care and quality of life for many patients and their caregivers. The new AI platform could also improve clinical trial design by identifying markers for various patient sub-populations’ treatment.

Original source: https://www.eurekalert.org/pub_releases/2019-02/aabu-bud022019.php